Seoul City to Host International Bio-Medical Conference on 7-8... Seeking 'With Corona' Digital Innovation

Online Event on 'Innovation in Bio?Medical Industry through Digital Transformation'
7th: World’s First Digital Therapeutics Developer CEO Keynote, Top Domestic and International Speakers Participate

[Asia Economy Reporter Lim Cheol-young] The Seoul Metropolitan Government announced on the 4th that it will hold the "5th Seoul Bio-Medical International Conference" over two days on the 7th and 8th to share domestic and international technology trends and facilitate technology exchange related to digital transformation in the bio and medical fields.

On the first day, top domestic and international speakers, including the CEO of the world's first digital therapeutics development company, will participate to present and share the latest information and success strategies regarding digital transformation. On the second day, to support the growth of startup companies, global open collaboration, investment briefings, and consulting sessions will be held with multinational pharmaceutical companies such as Johnson & Johnson.

Detailed information and the schedule for the "5th Seoul Bio-Medical International Conference" can be found on the official website. Considering the COVID-19 situation, the event will be held online, and the first day of the conference will be broadcast live on YouTube.

The keynote speeches on the 7th will feature Cory McCann, CEO of Pear Therapeutics, which received the first FDA approval for digital therapeutics in the United States, and Kim Hyung-wook, Chairman of the Korea Digital Health Industry Association. Following the keynote speeches, three sessions will be held on the theme of successful strategies for digital innovation in bio and medical fields, with 16 participants including domestic and international professors, researchers, and entrepreneurs.

Hwang Bo-yeon, Director of Economic Policy at the Seoul Metropolitan Government, said, "This conference will bring together top authorities in the digital transformation of the bio and medical fields for high-level lectures and discussions," adding, "In the with-COVID era, it will be a meaningful time to share insights on the development of the global bio-medical industry and to explore the direction of Seoul-style bio-medical policies."